Validation of peptide mapping with electrospray mass spectrometry for recombinant proteins of biopharmaceutical interest and its applications as an identity test and a characterization tool

Developments in Biologicals

Volumn 122, Issue , 2005, Pages 29-47

  Wei, Z ^a   Tous, G ^a   Yim, A ^a   Hope, J N ^a   Casas Finet, J R ^a   Folena Wasserman, G ^a   Schenerman, M A ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; RECOMBINANT PROTEIN;

CHEMISTRY; CONFERENCE PAPER; ELECTROSPRAY MASS SPECTROMETRY; PEPTIDE MAPPING; SENSITIVITY AND SPECIFICITY;

PEPTIDE MAPPING; PHARMACEUTICAL PREPARATIONS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33644622819     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (25)

1. Stone KL, Elliott JI, Peterson G, McMurray W, Williams KR: Reversed-phase high-performance liquid chromatography for fractionation of enzymatic digests and chemical cleavage products of proteins. Methods Enzymol 1990;193:389-412.
2. Dong MW: Tryptic mapping by reversed phase liquid chromatography. Adv Chromatogr 1992;3:21-51.
3. Hoff ER, Chloupek RC: Analytical peptide mapping of recombinant DNA-derived proteins by reversed-phase high-performance liquid chromatography. Methods Enzymol 1996;271:51-68.
4. Apffel A, Chakel J, Udiavar S, Swedberg S, Hancock WS, Souders C, Pungor E Jr: Application of new analytical technology to the production of a "well-characterized biological", in Brown F, Lubiniecki A, Murano G (eds): Characterization of Biotechnology Pharmaceutical Products. Dev Biol Stand. Basel, Karger, 1998, vol 96, pp 11-25.
5. Dougherty J, Snyder LM, Sinclair RL, Robins RH: High performance tryptic peptide mapping of recombinant bovine somatotropin. Anal Biochem 1990;190:7-20.
6. Kannan K, Mulkerrin MG, Zhang M, Gray R, Steinharter T, Sewerin K, Baffi R, Harris R, Karunatilake C: Rapid analytical tryptic mapping of a recombinant chimeric monoclonal antibody and method validation challenges. J Pharmac Biomed Anal 1997;16:631-640.
7. Bongers J, Cummings JJ, Ebert MB, Federici MM, Gledhill L, Gulati D, Hilliard GM, Jones BH, Lee KR, Mozdzanowski J, Naimoli M, Burman S: Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times? J Pharmac Biomed Anal 2000;21:1099-1128.
8. Allen D, Baffi R, Bausch J, Bongers J, Costello M, Dougherty J, Federici M, Garnick R, Peterson S, Riggins R, Sewerin K, Tuls J: Validation of Peptide Mapping for Protein Identity and Genetic Stability. Biologicals 1996;24:255-275.
9. Mundt AA, Cuillel M, Forest E, Dupont Y: Peptide mapping and disulfide bond analysis of the cytoplasmic region of an intrinsic membrane protein by mass spectrometry. Anal. Biochem. 2001;299:147-157.
10. Nguyen DN, Becker GW, Riggin RM: Protein mass spectrometry: applications to analytical biotechnology. J Chromatogr A 1995;705:21-45.
11. Wada Y: Advanced analytical methods for hemoglobin variants. J Chromatogr B Analyt Technol Biomed Life Sci 2002;781:291-301.
12. Mhatre R, Woodard J, Zeng C: Strategies for locating disulfide bonds in a monoclonal antibody via mass spectrometry. Rapid Commun Mass Spectrom. 1999;13:2503-2510.
13. Raftery MJ, Geczy CL: Identification of posttranslational modifications and cDNA sequencing errors in the rat S100 proteins MRP8 and 14 using electrospray ionization mass spectrometry. Anal Biochem 1998;258:285-292.
14. Zappacosta F, Huddleston MJ, Karcher RL, Gelfand VI, Carr, SA, Annan RS: Improved sensitivity for phosphopeptide mapping using capillary column HPLC and microionspray mass spectrometry: comparative phosphorylation site mapping from gel-derived proteins. Anal Chem 2002;74:3221-3231.
15. Chapman JP: Mass spectrometry of proteins and peptides. Humana Press, 2000.
16. Snyder AP: Interpretation of peptide and protein mass spectra. Interpreting Protein Mass Spectra, Oxford University Press. 2000, pp 155-264.
17. Carr SA, Hemling ME, Bean MF, Roberts GD: Integration of mass spectrometry in analytical biotechnology. Anal Chem 1991;63:2802-2824.
18. Mock K, Hail M, Mylchreest I, Zhou J, Johnson K, Jardine I: Rapid high-sensitivity peptide mapping by liquid chromatography-mass spectrometry. J Chromatogr A 1993;646:169-174.
19. Mock K: Routine sensitive peptide mapping using LC/MS of therapeutic proteins produced by recombinant DNA technology. Peptide Res 1993;6:100-104.
20. Ling V, Guzzetta AW, Canova-Davis E, Stults JT, Hancock WS: Characterization of the tryptic map of recombinant DNA derived tissue plasminogen activator by high-performance liquid chromatography-electrospray ionization mass spectrometry. Anal Chem 1991;63:299-2915.
21. Shen FW, Kwong MY, Keck RG, Harris RJ: The Application of tert-butylhydroperoxide oxidation to study sites of potential methionine oxidation in a recombinant antibody. Techniques in Protein Chemistry VII 1996;275-284.
22. Keck RG: The use of t-butyl hydroperoxide as a probe for methionine oxidation in proteins. Anal Biochem 1996;236:56-62.
23. Dougherty J, Mhatre R, Moore S: Using peptide maps as identity and purity tests for lot release testing of recombinant therapeutic proteins. Biopharm International 2003;54-58.
24. Garnick RL: Peptide mapping for detecting variants in protein products, in Brown F, Esber EE, Williams M (eds): Continuous Cell Lines - An International Workshop on Current Issues. Dev Biol Stand. Basel, Karger, 1991, vol 76, pp 117-130.
25. Harris RJ: Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. J Chromatogr A 1995;705:129-134.